Pacylex Pharmaceuticals Inc CEO Michael Weickert spoke with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The biotech firm is is developing a precision medicine solution for multiple common cancers by targeting a cellular process called myristoylation to selectively kill cancer.